Expertise in
14
conditions

Kaichun C. Wu

No. 127 West Changle Road, 
Xi'an, CN 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
14
conditions
No. 127 West Changle Road, 
Xi'an, CN 
OverviewLocationsClinical Research

Overview

Kaichun Wu practices in Xi'an, China. Wu is highly rated in 14 conditions, according to our data. Their top areas of expertise are Viral Gastroenteritis, Colitis, Budd-Chiari Syndrome, Endoscopy, and Colonoscopy.

Their clinical research consists of co-authoring 372 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

No. 127 West Changle Road, Xi'an, 710032, China
Other Locations
No. 127 Changle West Road, Xi'an, 710032, China
1 Xinsi Road, Xi'an, 710038, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Efficacy and Safety of Standardized Fecal Microbiota Transplantation for Moderate to Severe Crohn's Diseases
Efficacy and Safety of Standardized Fecal Microbiota Transplantation for Moderate to Severe Crohn's Diseases
Enrollment Status: Recruiting
Publish Date: November 29, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation in Patients With Moderate to Severe Ulcerative Colitis
Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation in Patients With Moderate to Severe Ulcerative Colitis
Enrollment Status: Recruiting
Publish Date: April 19, 2024
Intervention Type: Procedure, Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Clinical Study on the Effecacy and Safety of Different Dosing Regimens of Hemay007 in Patients With Active Ulcerative Colitis
A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Clinical Study on the Effecacy and Safety of Different Dosing Regimens of Hemay007 in Patients With Active Ulcerative Colitis
Enrollment Status: Terminated
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: Hemay007
Study Phase: Phase 2
Phase I Trial of Berberine in Subjects With Ulcerative Colitis
Phase I Trial of Berberine in Subjects With Ulcerative Colitis
Enrollment Status: Completed
Publish Date: August 03, 2021
Intervention Type: Other, Drug
Study Phase: Phase 1
View 2 Less Clinical Trial

372 Total Publications

Shaping the future of probiotics, live biotherapeutic products, and fecal microbiota transplantation: 30 scientific recommendations from the CHINAGUT Conference.
Shaping the future of probiotics, live biotherapeutic products, and fecal microbiota transplantation: 30 scientific recommendations from the CHINAGUT Conference.
Journal: iMeta
Published: July 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wu's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile